Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Endo, Inc. (NDOI : OTC)

• Company Description    Endo Inc. is a diversified pharmaceutical company. Endo Inc. is based in MALVERN, Pa. Number of Employees: 3,116

• Price / Volume Information    Yesterday's Closing Price: $20.99 Daily Weekly Monthly 20 Day Moving Average: 47,509 shares Shares Outstanding: 76.31 (millions) Market Capitalization: $1,601.82 (millions) Beta: 52 Week High: $31.40 52 Week Low: $20.00 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.43% -3.33% 12 Week -1.59% -17.23% Year To Date % %

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 9 Great Valley Parkway - Malvern,PA 19355 USA ph: 484-216-0000 fax: - investor.relations@endo.com http://www.endo.com

• General Corporate Information    Officers Scott A. Hirsch - Interim Chief Executive Officer and Director Paul Herendeen - Chairman and Director Mark T. Bradley - Executive Vice President; Chief Financial Officer Frank B. Raciti - Vice President; Controller; Chief Accounting Offic Paul Efron - Director Peer Information Endo, Inc. (GSAC) Endo, Inc. (CASI) Endo, Inc. (ALCD.) Endo, Inc. (OMNN) Endo, Inc. (CGPI.) Endo, Inc. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 29290D117 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/06/25 Share - Related Items Shares Outstanding: 76.31 Most Recent Split Date: (:1) Beta: Market Capitalization: $1,601.82 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.70 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $2.31 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/06/25

• Fundamental Ratios P/E Current FY Estimate: 9.09 Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.42 Price/Cash Flow: - Price / Sales: 1.02 EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -66.30% Sales Growth vs. Year Ago Period: -6.36% vs. Previous Quarter: -15.97% ROE 06/30/25 - - 03/31/25 - 0.51 12/31/24 - -14.52 ROA 06/30/25 - - 03/31/25 - 0.16 12/31/24 - -4.87 Current Ratio 06/30/25 - - 03/31/25 - 2.96 12/31/24 - 2.87 Quick Ratio 06/30/25 - - 03/31/25 - 2.02 12/31/24 - 1.84 Operating Margin 06/30/25 - - 03/31/25 - 0.48 12/31/24 - -10.65 Net Margin 06/30/25 - - 03/31/25 - -54.71 12/31/24 - -55.40 Pre-Tax Margin 06/30/25 - - 03/31/25 - -54.53 12/31/24 - -73.15 Book Value 06/30/25 - - 03/31/25 - 14.78 12/31/24 - 16.43 Inventory Turnover 06/30/25 - - 03/31/25 - 2.27 12/31/24 - 2.63 Debt-to-Equity 06/30/25 - - 03/31/25 - 2.15 12/31/24 - 1.93 Debt-to-Capital 06/30/25 - - 03/31/25 - 68.25 12/31/24 - 65.92

Powered by Zacks Investment Research ©